Latest by Larry Buhl
Federal Court Upholds Injunction Preventing Discharge of HIV-Positive Airmen
The U.S. Court of Appeals decision cites ‘U=U’ in its ruling.
Report: U.S. Must Act Fast to Reach HIV/AIDS Goals
The Centers for Disease Control and Prevention (CDC) finds that new HIV diagnoses have plateaued.
The Government's Free PrEP Isn't (Necessarily) Free
Ready, Set, PrEP expands access to pre-exposure prophylaxis meds, but it doesn't cover other costs.
How to Make an American AIDS Memorial
Activists and community members reflect on what it took to bring the Las Memorias AIDS Monument to life in Los Angeles.
Advocates Sound Alarm on Climbing HIV Rates for Latinx Communities
What will it take to end the HIV epidemic among Latinx people in the U.S.? Community advocates and researchers weigh in on the issue -- and offer solutions.
New Subtype of HIV Found, but Don't Panic
Despite the hype, a newly discovered subtype does not mean it's stronger or untreatable.
Behind The Government's Lawsuit Over Gilead's Alleged PrEP Patent Infringement.
A report on the research and activist work that led to the federal government taking nearly unprecedented action against the pharmaceutical company.
Descovy and Truvada Are Both Available for PrEP. But What's the Difference?
As Gilead pressures health care providers to switch to the newer drug, here's some information to make sure you can make the best decision for your health.
San Francisco's Meth Task Force Could Protect Progress in HIV Reduction
San Francisco is seeing a rise in ER visits and overdose deaths due to crystal meth use, particularly among African Americans, Latinx, the homeless, and other vulnerable groups.
Three STDs Are at an All-Time High. And Not Because of PrEP or More Risky Sex
While many people want to blame more risky sex and less condom use on the age of PrEP, the real reasons STDs are rising may have more to do with decreasing resources and programs to fight them.